Status:
COMPLETED
A Trial of a Comprehensive Breast Cancer Treatment Patient Decision Tool
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
Emory University
Conditions:
Breast Cancer
Eligibility:
FEMALE
21-84 years
Phase:
NA
Brief Summary
This study examines the impact of an online decision tool for patients with early stage invasive breast cancer. The study is a randomized controlled trial (RCT) of 444 newly diagnosed patients, recrui...
Detailed Description
Patients newly diagnosed with breast cancer face a series of complex decisions regarding locoregional and systemic treatment. Currently many of these decisions do not meet the definition of a high qua...
Eligibility Criteria
Inclusion
- Stage 1-2 invasive breast cancer diagnosis,
- DCIS
- Ability to read English
Exclusion
- Male
Key Trial Info
Start Date :
February 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2017
Estimated Enrollment :
537 Patients enrolled
Trial Details
Trial ID
NCT01840163
Start Date
February 1 2014
End Date
September 1 2017
Last Update
November 8 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan Medical School
Ann Arbor, Michigan, United States, 48109